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Comparative Genomic Analysis of Staphylococcus aureus CC80  
strains. 
 
Melhem E. Bilen 
 
ABSTRACT 
 
Staphylococcus aureus is a highly adaptive and versatile gram-positive bacterium and is 
considered one of the most isolated human pathogens and the most common cause of 
skin and soft tissue infections (SSTIs). The ongoing evolution of antimicrobial 
resistance namely the particularly methicillin-resistant strains of S. aureus (MRSA) has 
complicated the treatment of infections with such isolates. Global transmission of 
MRSA has been linked to international travel. However, in countries with a high 
prevalence of MRSA, imported cases are not easily distinguished from the domestic 
background prevalence. In this study we have selected ST80 MRSA strains isolated 
from clinical samples from Lebanon and Jordan for genome sequencing. DNA extracted 
from all isolates was prepared for sequencing, pooled together and run on Illumina 
MiSeq for paired-end 250-bp sequencing. Those isolates, found to be ST80, carried 
several virulence factors, namely PVL that causes a wide variety of diseases such as skin 
and mucosal lesions including necrotic hemorrhagic pneumonia. Additionally, 
intracellular adhesion proteins and clumping factors involved in biofilm formation and 
adhesion respectively were identified. Fibronectin binding proteins that play a role in 
invasion were expressed in all of our isolates. Moreover, exfoliative toxin, eta, which is 
the causative agent of staphylococcal scalded skin syndrome, was also detected. 
Nevertheless, different plasmids were identified in those isolates carrying several 
resistance genes towards Tetracyclines and Beta-lactams. Also, some isolates were 
shown to be resistant towards Lincosamide, Straptogramin and Macrolides. Finally, 
integrated phages, such as phi7401PVL and JS01 were identified in most of the isolates 
along with several CRISPR sequences that can be used in targeted therapies. Knowledge 
of epidemic MRSA clones can help in the development of effective strategies to aid in 
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optimizing treatment, and revealing the mode of pathogenicity. The detection of rare 
SCCmec cassettes along with rare combination of toxin encoding genes, resistance 
factors and other virulence determinants could be indicative of MRSA clones being 
imported and warrants further studies to better understand and deal with such strains. 
 
Keywords: Staphylococcus aureus, MRSA, ST80, Virulence determinants, Resistance 
genes. 
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Chapter One 
INTRODUCTION 
 
S. aureus is a common gram-positive bacterium known for its spherical shape and 
clusters. This bacterium resides in the epithelial lining of the upper respiratory tract 
and the skin (Abdelnour et al., 1993). It was discovered by a Scottish doctor 
Alexander Ogston during a knee operation, and studies showed that more than 20% 
of the human population are permanent carriers of that bacterium (Ogston, 1889). 
Fortunately, these diseases are mostly treatable and could be therefore prevented 
(Chambers et al., 2009; Moran et al., 2006). The ability of S. aureus to cause 
diseases is multifactorial, a combination of many virulent factors including toxins, 
secreted exoproteins, and cell surface-associated adhesins (Young et al., 2012). S. 
aureus resistance against a wide variety of antimicrobials is another problem and is 
increasing worldwide. Thus, the need to decipher the DNA is critical in order to 
follow the evolution of mutations, resistant genes and virulence factors.  Scientists 
obtained the capability to decode the genomic information of any biological system 
with the emerging of capillary electrophoresis based on Sanger sequencing. 
However, this approach has still its limitations in for instance information 
processing, measurability, rapidity and resolution, which always prohibit scientists 
from collecting the fundamental needed data (Fricke et al., 2013). Next-Generation 
Sequencing (NGS) on the other hand, enables the comprehensive examination and 
interpretation of genomes at low costs, higher speed and increased throughputs. It 
additionally, permits easier clinical diagnostics, effective therapy and prenatal 
diagnosis (Koboldt et al., 2013). Such recent technologies are rapidly developing and 
require new protocols for preparing DNA libraries and establishing updated and easy 
approaches to analyze data and revise the experimental design (Köser et al., 2012). 
In our study, several S. aureus strains were obtained from the American University 
of Beirut Medical center (AUBMC) and from Jordan University hospital with the 
aim of their molecular characterization. Genome sequencing was performed to 
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identify the genes responsible for resistance, virulence, and pathogenicity as well as 
to establish a comparative analysis and phylogeny. 
 
Objectives: 
 Screening the bacterial genome for the presence of virulence genes and 
pathogenicity islands. 
 Identifying genes responsible for resistance and understanding resistance 
mechanisms. 
 Perform a comparative analysis between the different S. aureus strains and 
their respective worldwide sequenced reference strains. 
 Trace the evolutionary lineage among the different isolates through the 
construction of a single nucleotide polymorphism (SNP) based phylogenetic 
tree. 
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Chapter Two 
LITERATURE REVIEW 
 
Member of the Firmicutes phylum, Staphylococcus aureus is frequently found on the 
skin and the epithelial surface of the respiratory tract. Known to be pathogenic, this 
bacterium is the origin of many diseases including boils (cutaneous infection), sinusitis 
(pulmonary infection), urinary tract diseases and several other illnesses. Disease-causing 
strains transmit the infection through the production of toxins or the expression of 
surface proteins. The evolution of S.aureus genome is in a race with scientists who are 
constantly trying to discover new antibiotics, track their origin and limit their evolution. 
Thus, typing and whole genome sequencing of the S. aureus’ genome could be a critical 
step towards the discovery of all the genome contents and the determination of new 
therapeutic methods. 
2.1. Virulence factors: 
 
S. aureus is known for causing a variety of infections and it does so with the aid of 
virulence factors. Virulence factors enable the bacterium to avoid the immune system, 
invade the host, release toxins that harm the host and adhere to surfaces. The majority of 
virulence factors can be grouped under two categories: 
 
2.1.1. Cell surface components: 
 
S. aureus has a group of surface proteins known as microbial surface components 
recognizing adhesive matrix molecules (MSCRAMM) that enable its attachment to the 
host and instigate colonization thus causing an infection. Virulence factors associated 
with the cell wall of S. aureus include capsular polysaccharides, which are found in 
around 90% of clinical isolates. Staphylococci capsules play a major role in virulence by 
blocking neutrophils from phagocitizing them (Johannessen et al., 2012). They also 
improve the colonization of the bacteria especially when it comes to mucosal 
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surfaces.  In addition to capsules, S. aureus has staphyloxanthin, which is a pigment that 
also helps it in evading neutrophils. If the biosynthesis of staphyloxanthin were to be 
inhibited, then this would render S. aureus vulnerable to innate immune responses 
(Clauditz et al., 2006). Furthermore, S. aureus has a wide variety of surface proteins 
such as fibronectin binding proteins (Fnb), collagen adhesion, protein A and clumping 
factors among others. These proteins enable the bacterium to adhere to the proteins of 
the host and establish an infection as well as hide the microorganism from the host's 
immune system (Eidhin et al., 1998); Staphylococcal protein A (spa) attaches to the Fc 
portion of the antibody to interfere with opsonization (DeDent et al., 2007). 
 
2.1.2. Secreted components: 
 
Virulence factors secreted by S. aureus constitute four major categories: toxins forming 
pores, exoenzymes, superantigens and various proteins (Schlievert et al., 
2010).  Leukocidin is a pore-forming toxin, at low concentration, it causes apoptosis 
while at high concentrations it causes cell lysis (Genestier et al., 2005). Lipase on the 
other hand is an exoenzyme found in S. aureus and its role is to degrade fatty acids 
(Dinges et al., 2000). Furthermore, superantigens are exotoxins produced by S. aureus 
and have the ability to engender several human diseases. Twenty different superantigens 
have been extracted from S. aureus and over 60 percent of S. aureus isolates have a 
minimum of one superantigen (Klutymans et al., 1997). In comparison to antigens that 
activate around 0.001% of T-cells, superantigens are capable of activating 5-30% of T-
cells. The activation of T-cells instigates the release of chemokines and cytokines from 
both T-cells and antigen presenting cells such as dendritic cells and macrophages. Those 
chemicals then will be responsible for establishing the symptoms of staphylococcal 
diseases such as staphylococcal toxic shock syndrome (STSS) (Ortega et al., 2010; 
Bachert et al., 2002). 
 
2.2. Pathogenesis: 
 
 5 
 
Infections are more prominent to occur when there is an open wound. A viral infection 
in the upper respiratory pathway would impair the mucosal linings and therefore render 
the host susceptible to S. aureus pneumonia (Rubinstein, 2008). Once S. aureus is 
exposed to the host tissue past the skin barrier and mucosal surface, its virulence factors 
will be up regulated. On the other hand, phagocytes usually reside in the epithelial and 
mucosal tissue, and trigger the immune system in case of tissue injury or bacterial 
invasion. Similarly, the host has pattern recognition molecules that sense the lipoproteins 
and the peptidoglycan layer of S. aureus, which facilitates inflammatory signaling 
including the recruitment of macrophages and neutrophils (Kim et al., 2011).  
S. aureus is also known to thrive well both outside and inside the cells of the host. S. 
aureus must avoid antibodies and complement component proteins in order for it not to 
be opsonized. To do so, S. aureus expresses on its wall clumping factor A also known as 
protein A, as well as other complement inhibitors; all of which can hinder opsonization 
(Gordon et al., 2008). In addition, S. aureus can hide inside epithelial cells and 
macrophages, but not in neutrophils since they are more challenging as evidenced by S. 
aureus infections being more invasive in patients with dysfunctional neutrophils. This 
however, doesn't imply that S. aureus do not have strategies to resist killings by 
neutrophils. One of its strategies is to secrete Extracellular Adherence Proteins (EAP) 
and Chemotaxis Inhibitory Proteins (CHIP) both of which interfere with the ability of 
neutrophils to attach to epithelial cells through interacting with intercellular adhesion 
moleculaes (ICAM-1) and impede neutrophils from recognizing chemotactic factors, 
respectively (Foster, 2005).  
Nevertheless, once the neutrophils get to the site of infection, they release antimicrobial 
products such as reactive nitrogen species, lysozyme, and proteases. S. aureus protects 
itself from reactive oxygen species by releasing antioxidant enzymes such as catalase 
and superoxide dismutase (Liu, 2009). S. aureus on the other hand, resists antimicrobial 
peptides that are aimed at negatively charged bacteria by altering its own surface charge. 
This pathogen also neutralizes and degrades antimicrobial peptides with staphylokinase 
and aureolysin, respectively (Sieprawska-Lupa et al., 2004). 
Another strategy used by S. aureus to evade neutrophils is through releasing toxins 
consisting of two components that are specific to human and not mouse cells. Till date, 
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the function of those toxins were not clearly elucidated. A combination of bacterial 
peptides known as phenol soluble modulin (PSM) have been also identified, and their 
role in virulence was mainly associated with CA-MRSA strains covering skin infections 
(Graves et al., 2010). 
Other than evading the immune system of the host, it is essential for the bacterium to 
obtain its nutrients especially iron in order to survive inside the human host. When an 
infection occurs, iron in the serum is made difficult to attain by binding to host proteins, 
beside the fact that 95% of iron is secluded inside host cells. When iron however is 
scarce, S. aureus secretes substances that have high affinity to iron like staphyloferrin 
and aureochelin. Similarly, when iron concentrations are low, S. aureus instigate the 
transcription of iron retrieval mechanism, which enables the bacterium to capture the 
haptoglobin and heme on the surface of the cell, then carry the complex into the 
cytoplasm and finally degrade the heme oxidatively (Hammer et al., 2011). 
There are also other virulence factors worth mentioning including the ability to form 
biofilms. Biofilms allow S. aureus to stick to plastic, counteract the defense of the host 
or antibiotics and produce variants of small colonies that allow it to survive when there 
are severe conditions by entering a metabolically inactive state (Liu, 2009). 
 
2.2.1. MRSA Pathogenesis 
 
It is evident that MRSA has distinct epidemiology especially when it comes to mortality 
and morbidity. It is separated into HA-MRSA and CA-MRSA, both of which are 
considered to be genotypically different targeting distinct communities but yet 
overlapping and causing diverse diseases (Evans, 2008). 
 
2.2.2. HA-MRSA: 
  
HA-MRSA has staphylococcal chromosomal cassettes (SCCmec) type I as well as 
SCCmec type II and III, which encode for a single or even multiple antibiotic resistance 
(Moroney et al., 2007), and hence capable of surviving in environments where 
antibiotics are frequently being used (Enright et al., 2012). 
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It’s noteworthy that once HA-MRSA is outside the healthcare environment, it will rarely 
cause diseases in humans unless they are predisposed.  As a consequence, it is indicated 
that HA-MRSA is one of S. aureus less vigorous strains and could only thrive where the 
competition is dependent on antibiotic pressure. Furthermore, studies performed showed 
that HA-MRSA are more susceptible to neutrophil killings and are less pathogenic when 
injected into mice systematically (Voyich et al., 2005). When comparing HA-MRSA 
and CA-MRSA strains, it was proven that HA-MRSA expressed reduced levels of PSM 
peptides, thereby signifying a probable defect in the regulation of virulence in HA-
MRSA (Wang et al., 2005). The expression of most virulence factors is controlled by the 
global regulator (agr), which is thought to be a prime pathogenesis factor in S. aureus. 
Clinical HA-MRSA isolates are arg- or arg+ genotypes. These genotypes (arg- or arg+) 
explain the non-pathogenicity of HA-MRSA in immunocompetent individuals. 
However, the same genotype might be favorable for the survival of HA-MRSA in 
healthcare environment (Shopsin et al., 2008); arg- enhances biofilm development and 
proliferation especially on plastic tubes (Vuon et al., 2000). 
 
2.2.3. CA-MRSA: 
 
CA-MRSA strains were alleged to be more virulent than HA-MRSA since they cause 
unconventionally severe infections like myositis and necrotizing pneumonia. However, 
due to insufficient comparative studies on CA-MRSA and methicillin sensitive S. 
aureus, it cannot be concluded that all CA-MRSA clones are more virulent (Bardley, 
2005). Yet, there is one CA-MRSA clone that has been proven to be exceptionally 
successful, known as USA300. USA300 has been found in Europe, Canada and the 
United States and reports show that it is related to severe infections in soft tissues, bone 
and skin (Miller et al., 2008). 
The virulence factor of CA-MRSA being most studied is the PVL. PVL was detected in 
the phage type 80/81 epidemic S. aureus strain. PVL, a two-component toxin, when 
injected into mice or rabbits, evident signs of apoptosis, neutrophil cytolysis, 
inflammation and necrosis were visible. Another important virulence factor is the type I 
arginine catabolic mobile element (ACME). It is speculated that ACME is horizontally 
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transferred from omnipresent skin commensal S. epidermidis. The two most significant 
gene clusters found in ACME are opp-3 and arc. opp-3 is an ABC-transporter, which 
functions in improving the survival of the bacteria on the skin through: resisting 
antimicrobial peptides, improving eukaryotic cell adhesion, and enhancing the uptake of 
peptide nutrients. Moreover, arc is an arginine deaminase system, which breaks down L-
arginine in order to provide the bacterium with ATP and raise the acidic pH of the 
human skin to one that is more convenient for bacterial colonization. Therefore, once S. 
aureus acquires ACME, then it might enhance the ability of CA-MRSA to colonize and 
consequently induce a skin infection once the skin barrier is disrupted. Evidence 
suggests that CA-MRSA is better at colonizing in comparison to HA-MRSA and MSSA; 
however, no direct evidence indicates that ACME actually aids in skin colonization (Liu, 
2009). 
 
2.3. Resistance evolution and mechanism:  
 
S. aureus was able to develop resistance mechanisms toward most of the antibiotics 
developed since 1950 after introducing Penicillin till 2002 when the first Vancomycin 
resistant S. aureus was reported (Figure 1).  
 
2.3.1. Penicillin resistance 
 
2.3.1.1. History  
 
Before the usage of the first S. aureus antibiotic, the mortality rate caused by these 
bacteria reached 80% (Skinner, 1941). In 1940, penicillin was introduced by Alexander 
Fleming as the first antibiotic against S. aureus and showed high efficiency in treating 
patients. Unfortunately, the first penicillin resistant strain was discovered in the hospitals 
in 1942. It spread quickly in the community and was responsible for 80% of the cases in 
1960 (Deurenber et al., 2008).  
 
2.3.1.2. Resistance mechanism: 
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Studies continued in order to discover the resistance mechanism of the S. aureus toward 
penicillin. S. aureus was able to inactivate penicillin through an enzyme called β-
lactamase which is encoded by blaZ gene and regulated by blaR1 and blaI. The pathway 
leading to β-lactamase synthesis is activated after the introduction to β-lactams through 
the cleavage of the blaR1 and blaI proteins (Lowy, 2003). 
 
2.3.2. Methicillin resistance  
 
2.3.2.1. History  
 
Methicillin was released in 1959 and used to treat patients carrying penicillin resistant S. 
aureus strains. However, methicillin resistant strains evolved in a short period of time 
and the first case was reported in a British hospital. MRSA spread quickly among 
different populations with severe symptoms and high number of nosocomial infections 
(Jevons, 1961). 
 
2.3.2.2 Resistance mechanism:  
 
mecA gene codes for the factors responsible for the resistance against methicillin in 
MRSA. It’s a part of the staphylococcal cassette chromosome mec that can be divided 
into five types: I, II, III, IV, and V. Type I, II and III were found to be associated with 
HA-MRSA while type IV and V were associated with CA-MRSA strains. Recently, 
novel SCCmec types (VI to XI) have been reported along with many subtypes (Turlej et 
al., 2011). mecA gene conferred resistance through the production of a modified plasma 
membrane bound enzyme called penicillin-binding protein 2a (PBP-2a). PBP-2a was 
able to perform its job having low binding affinity towards β-lactam antibiotics 
(Hartman et al., 1984).  
 
2.3.3. Quinolone-Resistant S. aureus  
 
2.3.3.1. History: 
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Fluoroqinolones were first introduced in 1980s to treat gram-positive bacteria with 
 S. aureus quickly developing resistance against this group of antibiotics (kirst et al., 
1998). 
 
2.3.3.2. Resistance mechanism:  
 
The mechanisms of resistance toward fluoroquinolones are based on mutations in the 
genes coding for topoisomerase IV or DNA gyrase, or on the presence of multidrug 
efflux pump. DNA gyrase is responsible for relieving DNA supercoiling and 
topoisomerase IV disentangles accumulated DNA. However, any mutation involving a 
single or multiple amino acids especially in the region of the enzyme-DNA complex 
results in affinity reduction. Mainly, mutations in the ParC subunit of topoisomerase IV 
and GyrA subunit in gyrase are responsible for this resistance. NorA is an example of an 
efflux pump that was first discovered in 1986 in a fluoroquinolone-resistant strain. NorA 
is able to secrete molecules similar to fluoroquinolones, like norfloxacin and 
ciprofloxacin. Therefore, the over expression of the NorA gene through a mutation in the 
promoter region, or a mutation in NorA gene regulators, or a mutation in any inducible 
or constitutive region, will lead to an increase in resistance. Moreover, the accumulation 
of resistant bacteria along with the low quinolone concentrations applied lead to an 
environment that enhances the growth of resistant mutants (Jacoby et al., 2005).  
 
2.3.4. Vancomycin resistance:  
 
2.3.4.1. History  
 
Vancomycin-resistant strains can be divided into 3 main groups: vancomycin-
intermediate S. aureus (VISA), heterogenous vancomycin-intermediate S. 
aureus (hVISA), and high-level vancomycin-resistant S. aureus (VRSA) (Jacoby et al., 
2005). In 1997, VISA was first discovered in Japan and then in other countries such as 
France, Brazil, and the United States (Smith et al., 1999). These strains showed 
resistance toward all glycopeptide antibiotics and had a phenotype characterized by a 
thick cell wall believed to reduce the efficiency of vancomycin penetration into the cell. 
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In 2002, VRSA strain was first identified from a catheter of a diabetic patient in 
Michigan carrying the mecA and VanA genes. VanA gene was shown to be encoded on a 
transposon Tn1546 in VRSA isolates, which conferred vancomycin resistance in 
enterococci (Chang et al., 2003; Weigel et al., 2003). Until 2010, eight patients suffering 
from VRSA were reported in the US and two others from Iran and India (Gould, 2010).  
 
2.3.4.2. Mechanism of resistance:  
 
Theories about the resistance of S. aureus to vancomycin started pointing towards the 
formation of a modified cell wall. Later on, it was proven that S. aureus showed an 
alteration in peptidoglycan biosynthesis resulting in a thicker cell wall with an irregular 
shape along with a decrease in cross linkage between peptidoglycans (Hanaki et al., 
1998). The cell wall contained more D-Ala-D-Ala residues that bind and trap vacomycin 
preventing it from reaching its target (Hanaki et al., 1998). Vacomycin resistance is also 
due to the conjugal transfer of vanA gene from the vancomycin-resistant Enterococcus 
faecalis and other enterococci (Showsh et al., 2001).  
 
 
2.4. Whole genome sequencing (WGS): 
 
2.4.1. Overview: 
 
New Generation Sequencing (NGS) enables the comprehensive examination and 
interpretation of genomes, trascriptomes and interactomes at lower costs, higher speed 
and increased throughputs (Mardis, 2009). Also, sequencing of DNA permits easier 
clinical diagnostics including: effective therapy, identification, and prenatal diagnosis 
(Gregg et al., 2014).  
 
2.4.2. WGS of S. aureus: 
 
Based on WGS, S. aureus was found to carry genomic islands with polymorphisms 
among different strains and with several genes encoding virulence factors (Baba, 2013). 
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Moreover, WGS was also used to study the antimicrobial resistance properties of 501 
unrelated S. aureus and compare it to results obtained from routine tests. The study 
showed that WGS was way more sensitive and accurate than any other commercial test 
(Stegger et al., 2014). Other findings targeted the pathogenicity islands using WGS in S. 
aureus strains, and three new pathogenicity islands were discovered including a toxic-
shock-syndrome toxin island family, exotoxin islands, and enterotoxin islands (Kuroda 
et al., 2001). In the UK, studies on MRSA outbreaks in a childcare center were done 
using WGS. The data showed that MRSA can be carried by a staff member and 
permitted the outbreak to endure for phases without any infection announcement (Harris 
et al., 2013). 
Additionally, 3A divergent mecA homologue (mecA (LGA251)) was discovered in the 
LGA251 genome located in a novel SCCmec element designated type-XI (Alvarez et al., 
2011). 
This technique also helped to study polymorphisms in different strains such as RN4220 
and NCTC8325 (Nair et al., 2001), or to compare livestock associated methicillin 
resistant strains isolated from Europe and Canada (Golding et al., 2010).   
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Figure 1: Evolution of antibiotics resistance of S. aureus from 1950 to 2000.  
 
2.5. Infection and Diseases:  
S. aureus can infect the majority of organ systems, studies showed that more than 20% 
of the human population is a permanent carrier of that bacteria (Young et al., 2012). This 
bacterium is most often spread to others by contaminated hands and biomedical 
materials. The skin and mucous membranes are usually an effective barrier against 
infection. However, if these barriers are breached (e.g., skin damage due to trauma or 
mucosal damage due to viral infection) S. aureus may gain access to underlying tissues 
or the bloodstream and cause infection (Odell, 2010). The spread of the infection ranges 
from being limited such as furuncle or carbuncle to expanding to other areas such as 
impetigo and cellulitis (Dryden, 2010). Furthermore, when the bacteria reaches the 
bloodstream, it causes bacteremia and hence it disperses to different sites of the body 
where it causes infections such as osteomyelitis, visceral endocarditis and pneumonia 
among others that might cause severe damage organ or kill the host. It should be noted 
that S. aureus strains also synthesize exotoxins and enzymes that most probably cause or 
enhance the asperity of certain diseases.  
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Chapter Three 
MATERIALS AND METHODS 
 
3.1. Ethical Approval 
 
Ethical approval was not required as clinical isolates were collected and stored as part of 
routine clinical care. Clinical isolates and patient records/information were anonymized 
and de-identified prior to the analysis. 
 
3.2. Bacterial isolates 
 
This study was conducted on S. aureus bacterial isolates, collected from the AUBMC 
(MB6, MB7, MB9 and MB12) and Jordan University Hospital (MB42). These samples 
were isolated from wound and were cultured overnight on Trypticase Soy Agar (Bio-
Rad, USA) medium for subsequent experimental work. 
 
3.3. DNA extraction 
 
Bacterial DNA was extracted using the Nucleospin Tissue kit (Macherey-Nagel, 
Germany) and following the manufacturer’s instructions.  
 
3.4. Genome sequencing: 
 
After fluorescent DNA quantification using Qubit 3.0 fluorometer (Life technologies, 
Carlsbad, CA), the samples are prepared for multiplexed, paired-end sequencing on a 
MiSeq Desktop Sequencer (Illumina, Inc., San Diego, CA). For each isolate, 1 ng of 
input DNA was used for indexing, and amplification steps were done using by the 
Nextera XT library prep kit (Illumina, Inc., San Diego, CA) and following the 
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manufacturer’s instructions. The subsequent clean up steps were performed using the 
AMPure XP PCR purification beads (Agencourt, Brea, CA) and again following 
instructions supplied by the Illumina manual. The resulting individual DNA libraries 
with fragments ranging from 500-1000bp were quantified by quantitative PCR on a 
CFX96 (Bio-Rad, USA) in triplicate at two concentrations, 1:1,000 and 1:2,000, using 
the Kapa library quantification kit (Kapa Biosystems, Woburn, MA). Based on the 
individual library concentrations, equimolar pools of no more than 12 indexed libraries 
were prepared at a concentration of at least 1 nM using 10 mM Tris-HCl (pH 8.0) and 
0.05% Tween 20. To ensure accurate loading onto the flow cell, the same quantification 
method was used to quantify the final pools. Finally the pooled paired-end libraries were 
sequenced on a MiSeq Desktop Sequencer to a read length of at least 250 bp.   
 
3.5. Analysis of sequencing results 
 
3.5.1. Genome assembly   
 
Genome assembly was done de novo using A5 with default parameters. This pipeline 
automates the processes of data cleaning, error correction, contig assembly, scaffolding, 
and quality control (Tritt et al. 2012). Reference mapping to the closest reference strains 
and de novo assembly were performed using the MIRA assembler v4.0.2 (Chevreux et 
al., 1999).  
 
3.5.2. Genome annotation using RAST 
 
The RAST server (http://rast.nmpdr.org) was used to annotate the obtained de novo 
assemblies, identification of protein encoding, rRNA, and tRNA genes, as well as 
assigning gene functions and predicting subsystems present in the genome (Aziz et al., 
2008; Overbeek et al., 2014). 
 
3.5.3. Determination of resistance genes, virulence genes, and pathogenicity 
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Resistance and virulence genes found in the bacterial genomes were determined by 
mapping the WGS data to online databases. The SEED viewer service from RAST 
proved to be very useful in extracting all the genetic elements found on the sequenced 
bacterial genomes. It was used, combined with the web tools provided by the Center for 
Genomic Epidemiology (CGE) website (www.genomicepidemiology.org) to get a 
detailed list of the genetic elements in question. The ResFinder 2.1 web server was used 
to identify acquired antimicrobial resistance genes present on the bacterial genome, the 
job was run with the website’s default parameters (Zankari et al., 2012). ResFinder 
detects the presence of resistance genes, but does not confirm their functional integrity 
and expression. Resistance to acquired mutations in housekeeping genes, is another 
feature, the service misses. Hinging on the ResFinder hits, a resistance profile was 
established using phenotypes from previous published studies.  Virulence genes were 
determined using the VirulenceFinder 1.2 service from the same website (Joensen et al., 
2014).  
 
3.5.4. Multi-locus sequence typing (MLST) and plasmid detection 
 
MLST typing of the isolates was done by mapping the WGS data to an online database 
using CGE’s MLST 1.7 server (Larsen et al., 2012). Plasmid detection was also 
achieved using the website’s PlasmidFinder 1.2 web service with a 95% selection 
threshold (Carattoli et al., 2014).  
 
3.5.5. Phage detection 
 
Phage detection was done using the publically available Phage Search Tool (PHAST) 
(http://phast.wishartlab.com/index.html) (Zhou et al., 2011). This tool provided us with 
site of phage integration and assigns a phage family. Sequences were annotated using 
RAST. 
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3.5.6. Circular visualization  
 
Circular genome visualization was done using two different tools. Comparative figure 
were generated using the CGView server at the publically available Stothard Research 
Group website (http://stothard.afns.ualberta.ca/cgview_server/) (Grant & Stothard, 
2008). Informative figures for each sample were also generated using DNAPlotter 
release 1.11 (Carver et al., 2009). 
 
3.5.7 SNPs detection and construction of a phylogenetic tree 
 
SNPs calling, filtering and alignment were done using CSI Phlogeny 1.0a web service 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny) (Kaas et al., 2014). Maximum likelihood 
Tree visualization was done using FigTree v1.4.2.  
3.5.8. Clustered regularly interspaced short palindromic repeats (CRISPR) 
detection 
 
CRISPRFinder was used for detection of CRISPRs in locally created data and 
consultation of CRISPRs present in the database. Also, information on the presence of 
CRISPR-associated (cas) genes were collected (Grissa et al. 2007). 
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Chapter Four 
RESULTS 
 
4.1. Genomes overview:  
 
General features of the isolates were determined using the RAST server and were 
tabulated in a comparative way (Table 1). 
Table 1: General features of the isolates in terms of size, number of contigs, GC 
content, contigs size, number of coding sequences, number of subsystems and RNAs.  
  
4.2. MLST typing: 
All isolates taken in this study were identified using MLST 1.7 and showed to be ST80 
(Table 2).  
Table 2: The results obtained from MLST 1.7 server using CGE were tabulated in a 
comparative way in order to check similarities between the different strains. All five 
strains were identified as ST80 with a 100% identity for seven loci arc, aroe, glpf, gmk, 
pta, tpi, yql (Table 2). 
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4.3. Virulence factors 
 
Virulence factors obtained using VirulenceFinder 1.2 service, were grouped in a table 
showing the genotypic differences between the isolates and between CC80 reference 
strain (ST_11819-97). All isolates showed to have the same set of genes that code for 
intracellular adhesion proteins (IcaA, IcaB, IcaC, IcapR). Additionally, the Panton-
Valentine leukocidin (LukF-PV, lukS-PV), exotoxins, complement and fibrinogen 
binding proteins (fib) were detected in all the isolates (Table 3). 
 
Table 3: This table shows a summary of the detected virulence factors, a more 
comprehensive table about virulence factors can be found in Annex I. 
 
 Isolates MB46 MB6 MB7 MB9 MB12 CC80 
Reference 
Strain 
Protein 
function 
Virulence 
factors 
Virulence 
factors 
Virulence 
factors 
Virulence 
factors 
Virulence 
factors 
Virulence 
factors 
Intracellular 
adhesion 
proteins 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
IcaA,Ica
B,IcaC 
IcaD,Ica
pR 
IcaA,Ica
B,IcaC 
IcaD,Ica
pR 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
Exfoliative 
toxin A 
eta eta eta eta eta eta 
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lukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-
PV, lukS-
PV 
LukF-PV, 
lukS-PV 
Clumping 
factor ClfB, 
fibrinogen 
binding 
protein 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
Fibronectin 
binding 
protein  
FnbA and 
FnbB 
FnbA and 
FnbB 
FnbA and 
FnbB 
FnbA and 
FnbB 
FnbA 
and 
FnbB 
FnbA and 
FnbB 
 
4.4. Resistance genes:  
 
 Resistance genes in all isolates and CC80 reference strain ST_11819-97 
were identified using ResFinder. Different resistance patterns were detected, with all 
being tetracycline and β-lactam resistant. MB46 was only resistant to lincosamide, 
streptogramin B and macrolides resistant, whilw both MB9 and CC80 reference strain 
were also resistant to the macrolides. All isolates except MB7 were aminoglycoside 
resistant, and four isolates (MB46, MB6, MB9 and MB12) were resistant to fusidic acid 
(Table 4). 
 
Table 4: Resistance patterns in ST80 isolates. Tetracycline resistance (tet(k); tet(38)), β-
lactam resistance (mecA, blaZ); Lincosamide resistance (InuA); Macrolide resistance 
(erm(C); mph(C)); Aminoglycoside resistance (ant(6)-la; aph(3’)-lll); Fusidic acid 
resistance (fusB); Streptogramin B resistance (msr(A)). 
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4.5. Plasmids content: 
 
PlasmidFinder, revealed that all the S. aureus isolates carried plasmidic rep gene 
sequences. All isolates had rep7, MB46 only had rep21, while MB46 and MB9 had 
rep10. Finally, rep 20 detected in all samples except in MB7 and the CC80 reference 
strain (table 1.5). 
Table 5: Plasmids detected in the CC80 isolates and CC80 reference strain. 
  
 
4.6. Phage detection 
 
At least two phage sequences were identified in each sample, with some sharing 
common phages such as phi7401PVL which was detected in MB12, MB9, MB6, MB46 
and CC80 reference strain ST_1181-97 (Table 6).  
 
Table 6 PHAST analysis showing the types of phages, length, position, completeness, 
score, #CDS (coding DNA sequence), and %GC for all studied isolates along with the 
CC80 reference strain. 
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4.7. CRISPRs  
Most prokaryotic genomes have structures called CRISPRs. They are made up of 25-50 
base pair repeats set apart by specific spacer sequences of comparable length, which 
come from prior virus exposures. All isolates contained several CRISPR sequences in 
their genome. The position and length of these sequences were identified in each isolate 
(Table 7). 
 
Table 7: CRISPRFinder analysis in the different isolates showing the start and end 
positions of CRISPRs and their length. 
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4.8. Circular genomes comparison and visualization  
 
The visualization of each isolate in terms of coding DNA sequence, rRNA, tRNA and 
phages was done through DNAPLOTTER (Figure 2). Also, each isolate was compared 
to the CC80 reference strain and results were generated by CGview (Figure 3). Only 
isolate MB46 was chosen as a representative and shown graphically in this section, the 
rest of the circular genome displays can be found in Annex I.  
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Figure 2: Genome atlas of S. aureus MB46. This graphical representation of the genome 
was generated using DNAPLOTTER. From outside to inside: S. aureus, coding DNA 
sequence on the forward strand (blue); S. aureus coding DNA sequence on the reverse 
strand (red); ribosomal RNA genes (yellow); tRNA genes (green_ GC% (Black below 
mean and grey above mean); GC skew. The purple arrows represents the phages 
detected in the genome.  
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Figure 3: Genomic comparison between S. aureus MB46 and ST80 reference strain 
ST_11819-97. This graphical representation of the genome was generated using CGview 
server. From outside to inside: S. aureus, coding DNA sequence on the forward strand, 
S. aureus coding DNA sequence on the reverse strand, rRNA and tRNA are colored 
according to the legend inside the first two tracks, third track, which is the blast track 
(Reference strain 11819_97), represents the positions covered by the BLASTN 
alignment. Inside this track, white regions indicate parts of the input sequence that did 
not yield a blast hit, light pink represents parts of the input sequence that yield one blast 
hit, darker pink regions indicate parts of the input sequence that yield several blast hits 
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(ie overlapping hits). These often include rRNA or tRNA genes or repetitive sequences 
for which several similar sequences in the CC80 reference strain are found. Then the GC 
content is shown in black and finally the positive and negative GC skew are colored 
green and purple, respectively. 
4.9 Phylogenetic tree.  
 
A maximum parsimony phylogenetic tree was generated by CSIPhylogeny based on 
high quality SNPs and manipulated using FigTree v1.4.2. The branches of our CC80 
isolates along with the reference strain (ST 11819-97) and a Dutch CC80 MRSA were 
colored by yellow. The remaining branches represent the clustering of the different 
clonal complexes (CC30, CC398, CC45, CC59, CC93, CC5, CC8 and CC1) and were 
colored in blue.   
 
 
Figure 4 An urooted maximum parsimony SNP-based phylogenetic tree including the 
five isolates along with ten reference strains of different clonal complexes.  
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Chapter Five 
DISCUSSION 
 
5.1. PVL: 
 
 All the isolates in this study were found to be PVL positive. S. aureus strains encoding 
the PVL toxin, a prophage-encoded bicomponent pore-forming protein, are highly 
pathogenic and are associated with primary skin infections and life-threatening invasive 
diseases (Shrestha et al., 2014). PVL is a β-pore-forming toxin regarded as a cytotoxin 
(Pervost et al., 1995), which is mainly detected in CA-MRSA (Szmiegielsk et al., 1999; 
Kaneko et a., 2004). Phi7401PVL phage was detected in the genome of three of our 
isolates (MB46, MB6, MB12) along with the reference strain (ST_11819-7). This phage 
carried the PVL encoding genes precursors in all the former isolates except MB6. This 
might be the outcome of a deletion event that has occurred within the phage genome 
before being integrated. Our findings are similar to those reported by Mariem et al., 
(2013) where FG80 S. aureus isolates became more pathogenic upon acquiring 
phi7401PVL (Mariem et al., 2013). It’s noteworthy however, that different types of 
phages can carry the PVL encoding genes. The majority of the isolates that were studied 
to track the evolution of CA-MRSA in Europe, were found to carry the PVL encoding 
genes on phiSA2, which was not detected in any of our isolates (Stegger et al., 2014). 
In Lebanon a high percentage of MRSA were found to be PVL positive (Tokajian et al., 
2010; Harastani et al., 2014). Interestingly, and in Denmark, the PVL positive CC80-
ST80-IV isolates are the predominant cause of CA-MRSA infections with a large 
majority of patients having family relationships in the Middle East (Goering et al., 
2009). 
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5.2. Biofilm Formation 
 
Biofilm formation enables S. aureus to persist and to resist the host immune response by 
shielding them from opsonophagocytosis and antimicrobial agents (Foster, 2005). 
Biofilm formation requires two consecutive steps: primarily the adhesion of cells to a 
concrete substrate, followed by its adhesion to nearby cells creating multiple layers of 
bacteria. Cramton et al. (1999), showed that isolates having the ability to form biofilm 
carried the ica operon, which was also detected in all the isolates undertaken in this 
study. ica operon (icaA, icaB, icaC and icaD) mediates the production of polysaccharide 
intercellular adhesion (PIA). PIA is mainly composed of N –acetylglucosamine used for 
biofilm formation and invasion (Frank et al., 2011). Additionally, ica is needed for the 
expression of two other virulence determinants namely the genes encoding for 
extracellular matrix proteins (EMP) and EAP. Genes encoding both proteins were 
detected in all the studied isolates, which further demonstrated their pathogenicity. 
Interestingly, In most isolates (MB46, MB6, MB7 and MB12) the EAP gene was 
detected in close proximity with the JS01 phage sequence. Moreover, EAP was recently 
reported as being an important factor involved in inhibiting neutrophil serine proteases, 
and thus promoting S. aureus infection (Johnson et al., 2014). This finding increases our 
understanding into the complexity of S. aureus pathogenesis. 
Additionally, the ability of S. aureus to colonize was linked to several surface proteins 
having high affinity to bind to MSCRAMMs. There proteins recognize fibronectin (Fn) 
such as FnBPA and FnBPB and are known to be essential for primary attachment 
(McCourt et al., 2014). Genome annotation of the isolates in this study revealed the 
presence of FnBPA and FnBPB. FnBPA is a protein that is found on the surface of S. 
aureus (Jönsson et al., 1991), and it attaches to both fibrinogen and Fn. This protein acts 
in mediating adhesion and invasion (Sinha et al., 2000; Saddif et al., 2001), and 
disrupting the genes coding for FnBP was associated with reduced invasiveness and 
adherence (Sinha et al., 2000).  
Furthermore, FnBPs mediate the attachment of this pathogen to Fn coated biomaterials 
and were reported as being important factors enhancing internalization in experimental 
endocarditis (Menzies et al., 2003). On the other hand, Saddif et al. (2001) revealed that 
 29 
 
the uptake of S. aureus by osteoblasts was linked to FnBPs. Disrupting the genes coding 
for these proteins blocked internalization, which further supports the essentiality of these 
factors as important virulent determinants.  
5.3. Clumping factors 
 
ClfA and ClfB, both of which were detected in the sequenced isolates, are clumping 
factors found on the surface of S. aureus. ClfA has high binding affinity to fibrinogen, 
which is a precursor of fibrin (Hawiger et al., 1982). Fibrin is one of the foremost 
components of plasma, which could be additionally found on biomedical materials 
(Vaudaux et al., 1989; 1995; Herrmann et al., 1993; Moreillon et al., 1995). Both ClfA 
and ClfB are members of the MSCRAMMs family (McDevitt et al., 1994; Ní Eidhin et 
al., 1998) sharing common characteristics with other cell surface proteins, but are 
characterized by their R region which is made up of serine and aspartic acid dipeptides 
(Josefsson et al., 1998). Several studies conducted on human platelets showed the role of 
ClfA and ClfB in aggregation (Brien et al., 2002). ClfB also mediates the adhesion of S. 
aureus to type I cytokeratin enhancing nasal colonization (Brien et al., 2002). Genome 
annotation of the isolates revealed the presence of both clumping factors. Similarly, 
previous studies also reported the presence of both factors in different subtypes 
including: ST8, ST5, ST256, ST88, ST188, ST552. On the other hand, and in contrast to 
our results, other ST80 isolates had only ClfA (McDevitt et al., 1994; Moreillon et al., 
1995; Vaudaux et al., 1995). This illustrates that although the isolates undertaken in this 
study were typed as ST80, but were not exactly identical to other similar subtypes 
isolated from elsewhere, and thus studying such factors would be particularly important 
when testing for vaccines (McCarthy et al., 2010).  
 
5.4. Exfoliative toxin 
  
 S. aureus produces different types of toxins including enterotoxins, exfoliative toxins 
and toxic shock syndrome toxin-1 (TSST-1) (Dinges et al., 2000). Exfoliative toxins 
have a serine protease domain, which acts on desmosomal cadherins leading to SSSS 
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(Shamez, 2003). SSSS is associated with two exfoliative toxin coding genes, namely eta 
and etb, the expression of which is regulated by agr. eta was commonly detected in 
isolates from Africa and USA, while etb was dominant in Japan (Bukowski et al., 2010). 
Both toxins were detected in MSSA and MRSA at different frequencies, with a 3-4% of 
MSSA having either eta or etb and 10% MRSA carrying eta. (Megevand et al., 2010; 
Silia et al., 2009). Moreover, etd, which is another toxin in this group, was detected in 
strains identified as belonging to CC80 (Holmes et al., 2005). 
In this study all five isolates had eta and/or etb encoding genes. Likewise, in China, 
studying 108 S. aureus isolates taken from different hospitals had the eta gene within 
different clonal complexes such as CC5, CC7, CC25 and CC59 (Xie et al., 2011). 
However, eta and etb were both detected in S. aureus recovered from Taiwanese 
children with SSSS or staphylococcal toxic shock syndrome (STSS) (Chi et al., 2006). 
It’s noteworthy that all the isolates in this study, had both the eta and PVL encoding 
genes, which was in harmony with previous results from Lebanon (Harastani et al., 
2014). Contrary to the CC80 isolates, Kurt et al. (2013) found that PVL and exfoliative 
toxins were mutually exclusive in CC121 isolates.  
 
5.5. Resistance patterns: 
 
Differences in the antibiotic regimen that exists between countries contributed to the 
development of heterogeneous strains. CA-MRSA lineages are genotypically and 
phenotypically unrelated to the multi-drug resistant HA-MRSA. Common within CA-
MRSA is that fact that they are generally susceptible to non-β-lactam antibiotics 
(Deresinski et al., 2005). The mechanisms underlying the unique SKF (Strepromycin, 
Kanamycin, Fusidic acid) resistance profile previously reported within the CC80 strains 
collected from Jordan and Lebanon, were revealed upon the annotation of the isolates 
(Harastani, et a., 2014). Resistance to Streptomycin was found to be through the ant(6)-
Ia gene, which codes for an O-adenyltransferase  that inactivates the drug through 
catalyzing the ATP-dependent adenylation of the drug (Shaw et al., 1993). Additionally, 
aph(3’)-111 gene which codes for O-phosphotransferase that renders the bacterium to be 
resistant to vancomycin, Neomycin, Paromomycin, Kanamycin and Gentamycin B was 
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also detected. Finally, resistance to fusidic acid is another common important 
characteristic feature of CC80 strains, and which was previously observed and reported 
by several studies conducted in the region and elsewhere (Tokajian et al, 2010; 
Harsatani et al., 2014, Stegger et al., 2014, Goering et al., 2009). Sequencing of the 
isolates revealed the presence of the fusB gene. The fusB gene was found to be located 
on phage-related resistance islands in S. epidermidis (Hsiao et al., 2011), and on p11819-
97 plasmid in CC80 strains, which additionally carried the blaZ gene (Stegger et al., 
2014).  
 
Plasmids are classified based on the replication proteins (REP) (Jensen et al., 2010). 
Plasmids may carry a single rep gene or a combination of rep genes, with each 
combination of rep forming a plasmid group of S. aureus (pGSA). We have detected the 
presence of different rep genes associated with a set of other genes encoding for 
resistance. rep7, which was detected in all our isolates is classified as pGSA2. pGSA2 is 
known to carry four variable resistance encoding genes being namely cat 
(chloramphenicol resistance), tetK (tetracycline resistance) str (streptomycin resistance), 
vgaA (pleuromutilin resistance) (McCarthy et al., 2012). This however, matched with the 
annotation results were tetK was one of the detected genes. Moreover, rep20 which was 
detected in MB46, MB6, MB9 and MB12, is classified as pGSA31 and has blaZ, cadA, 
tetK as core genes, while rep10 is pGSA3 carrying only one core gene which is ermC, 
and was also detected in this study upon annotation. Finally, rep21, which is pGSA10, 
carries variable resistance genes including blaZ, which was also detected upon 
annotation.  
 
5.7. CRISPR identification: 
 
Most prokaryotic genomes have structures called CRISPRs. They are made up of 25-50 
base pair repeats set apart by specific spacer sequences of comparable length, which 
come from prior virus exposures (Marrafini et al., 2010). cas genes and CRISPRs are 
found in the genomes of archaea (≈90%) and bacteria (≈40%) (Kunin et al., 2007; Grissa 
et al., 2007) and they have been proven to play a role in sequence-targeted immunity 
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towards plasmids (Marraffini et al., 2008) and phages (Brouns et al., 2008; Barrangou et 
al., 2007).  This system could be responsible for the relatively lower number of phage-
associated virulence factors and antibiotic resistance genes detected in ST80 MRSA in 
comparison to other widespread MRSA strains (Monecke et al., 2008; Walther et al., 
2009).  Furthermore, it has been proposed that the transfer of CRISPRs occurs via 
horizontal gene transfer by mega-plasmid (greater than 40 kb) conjugation, with their 
origin remaining unfamiliar (Godde et al., 2006). Based on CRISPRfinder, the studied 
isolates had CRISPRs sequences at different positions within their genomes. However, 
only one CRISPR system identified in MB9, was detected within a putative mobile 
genetic element that extends from base pair number 1951327 to 1951424. Accordingly, 
and since CRISPR was detected on a mobile element, we propose and in harmony with 
Golding et al. (2010), that additional mechanism of mobilization to other Staphylococcus 
spp. is plausible (Golding et al., 2010). CRISPRs are widely being studied nowadays in 
terms of developing new therapeutic approaches. Antimicrobial agents are uncapable of 
selectively killing specific members within a mixed microbial population since they are 
designed to target growth functions or conserved prokaryotic cellular pathways. 
Therefore, sequence specific and programmable antibiotics are being developed using 
Cas9 (Jinek et al., 2012; Gasiunas et al., 2012), and through introducing an RNA-guided 
nuclease by bacteriophages. When the nuclease is reprogrammed to target genes coding 
for antibiotic resistance in staphylococci, it will degrade plasmids carrying antibiotic 
resistance genes, and consequently reduce the transfer of plasmid-borne resistance genes 
to avirulent staphylococci (Diep et al., 2006; Weigel et al., 2003). Reprogrammed Cas9 
directed towards virulence genes could help in targeting pathogenic strains of S. aureus 
(Bikard et al., 2014).  
 
5.8. Phylogeny 
 
Phylogenetic examination determined S. aureus MW2 to be the out-group most closely 
related to our CC80 isolates when compared to the remaining genome sequences of 
different clonal complexes, and this was similar to what was previously reported 
(Stegger et al., 2014).  
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All our isolates, along with the reference strain (ST_18819-97) and the Dutch ST80 
(S1475), were clustered together. This is predictable since they all belong to the CC80 
and share common characteristics in terms of virulence, resistance and other genomic 
features. Only MB6 was distantly placed, this can be attributed to differences seen in its 
resistance profile and to the high number of SNPs detected when aligned against the 
CC80 reference strain. 
 
5.9. Importance of this study 
 
To summarize, the WGS of each isolate helped us in roughly characterizing most of the 
genome and identifying several genes involved in virulence, resistance and many other 
sequences corresponding to different types of mobile elements. PVL was detected along 
with several factors involved in biofilm formation, invasion and toxin production. Also 
different resistance profiles were linked to the underlying resistance mechanisms. This 
can improve the appropriate use of antimicrobials by promoting the selection of the 
optimal antimicrobial drug regimen to achieve best clinical outcome. Finally, WGS cuts 
the time needed to diagnose infections, improving patient care, optimizing clinical 
outcome and enabling more precise and appropriate individualized therapies, improving 
patient care and optimizing clinical outcome. 
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Chapter Six 
CONCLUSION 
 
 In this study, which is the first in Lebanon, genome sequencing of CC80 S. 
aureus isolates from Lebanon and Jordan allowed us to characterize our samples 
in terms of virulence, resistance, mobile element, CRISPRs and phylogeny  
 
 All our isolates were PVL positive and carried genes encoding for factors 
involved in biofilm formation such as icaA, icaB, icaC, icaD, EMP and EAP. 
 
 Fnb were present in all our isolates illustrating invasiveness. 
 
 All the isolates had clumping factors A and B, both of which are linked to 
adhesion. 
 
 The eta gene coding for exfoliative toxin A and which plays a role in 
Staphylococcal Scalded Skin Syndrome was also detected. 
 
 Different resistance patterns of all isolates were detected, with all being 
tetracycline and β-lactam resistant, MB46 only lincosamide, streptogramin B and 
macrolide resistant, and both MB9 and CC80 reference strain were also resistant 
to macrolide. All isolates except MB7 were aminoglycoside resistant, and three 
isolates (MB46, MB6 and MB9) were fusidic acid resistant 
 
 Plasmids were identified in all our isolates and were correlated to the resistance 
genes found in each.  
 
 Integrated phages were detected in all our isolates showing the potential of 
resistance gene transfer.  
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 CRISPR sequences along with cas were identified. The latter shows a great 
promise for future medicinal use targeting multidrug resistant strains. 
 
 Phylogenetic examination determined S. aureus MW2 to be the out-group most 
closely related to our CC80 isolates when compared to the remaining genome 
sequences of different clonal complexes. 
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ANNEX I 
Table 8: Comparative table showing the virulence factors profile of each isolate along 
with the CC80 Reference Strain.  
 
CC80-samples MB46 MB6 MB7 MB9 MB12 CC80 
reference 
Strain 
Protein function virukence 
factors 
virulence 
factors 
virulence 
factors 
virulence 
factors 
virulence 
factors 
virulence 
factors 
Intracellular 
adhesion proteins 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
IcaA,IcaB,I
caC 
IcaD,IcapR 
IcaA,IcaB,
IcaC 
IcaD,Icap
R 
IcaA,IcaB,I
caC 
IcaD,IcapR 
IcaA,IcaB,I
caC 
IcaD,IcapR 
IcaA,IcaB,I
caC 
IcaD,IcapR 
extracellular 
adherence proteins 
eap eap eap eap eap eap 
Ser-Asp rich 
fibrinogen-binding 
portein H 
sdrH, 
sdrD, 
sdrE, 
sdrC 
sdrH, sdrE,  
sdrC 
sdrH, 
sdrD, 
sdrE,  
sdrC 
sdrH, sdrD, 
sdrE,  sdrC 
sdrH, sdrD,  
sdrC 
sdrH, sdrD, 
sdrE, sdrC 
capsular 
polysaccharide 
biosynthesis protein  
cap5P,N,
M,F,E,A/c
apA,capB 
cap5P,N,M,
F,E,A/ 
capA,capB 
cap5M,N,
A,E,F,P/c
apA,B 
cap5P,N,M
,F,E,A/ 
capA,capB 
cap5P,N,M,
F,E,A/ 
capA,capB 
cap5P,N,M,
F,E,A/ 
capA,capB 
capsular 
polysaccharide 
synthesis enzyme 
cap8O,K,
L,J,I,H,G 
cap8O,K,L,
J,I,H,G 
cap8O,K,
L,J,I,H, 
cap8O,K,L,
J,I,H, 
cap8O,K,L,
J,I,H, 
cap8O,K,L,
J,I,H, 
superantigen like 
protein 
set3,5,15/s
al 
set3,5,15/sa
l 
set3,5,15/s
al 
set3,5,15/sa
l 
set3,5,15/sa
l 
set3,5,15/sa
l 
spa 
immunoglobulin G 
binding protein A 
+ + ? + + + 
Thermonuclease  nuc nuc nuc nuc nuc nuc 
polysaccharide 
biosynthesis protein  
capD capD capD capD capD capD 
type VII secretion 
protein 
esaA and 
essC 
esaA and 
essC 
esaA and 
essC 
esaA and 
essC 
esaA and 
essC 
esaA and 
essC 
protein secretion essA essA essA essA essA essA 
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system  
ESAT-6/WXG100 
family secreted 
protein EsxA/YukE 
esxA esxA esxA esxA esxA esxA 
virulence factor 
EsxB family protein 
esxB esxB esxB esxB esxB esxB 
EsaC protein within 
ESAT-6 gene 
cluster 
esaC esaC esaC esaC esaC esaC 
Putative secretion 
accessory protein 
EsaB/YukD 
esaB esaB esaB esaB esaB esaB 
putative secretion 
system component 
EssB 
essB essB essB essB essB essB 
serine protease splF,A,B,
C 
splF,A,B,C splF,A,B,
C 
splF,A,B,C splF,A,B,C splF,A,B,C 
lukF-PV, lukS-PV LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
LukF-PV, 
lukS-PV 
serine V8 protease sspA sspA sspA sspA sspA sspA 
cysteine protease sspB,C,B2 sspB,C,B2 sspB,C,B2 sspB,C,B2 sspB,C,B2 sspB,C,B2 
hemolysin-
delta/beta 
hld, hlb hld, hlb hld, hlb hld, hlb hld, hlb hld, hlb 
alpha-hemolysin 
precursor 
hla hla hla hla hla hla 
gamma-hemolysin 
component B 
precursor 
hlgB hlgB hlgB hlgB hlgB hlgB 
gamma-hemolysin 
component C 
hlgC hlgC hlgC hlgC hlgC hlgC 
gamma-hemolysin 
chain II precursor 
hlgA hlgA hlgA hlgA hlgA hlgA 
clumping factor 
ClfB, fibrinogen 
binding protein 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
clfB,fib, 
clfA 
 53 
 
bifunctional 
autolysin Atl 
atl atl atl atl atl atl 
von Willebrand 
factor-binding 
protein 
vwb vwb vwb vwb vwb vwb 
cell wall associated 
fibronectin-binding 
protein 
ebh   ebh ebh ebh ebh 
cell surface elastin 
binding protein 
ebpS ebpS ebpS ebpS ebpS ebpS 
putative enterotoxin 
type A 
SEntA SEntA SEntA SEntA SEntA SEntA 
exotoxin SExo SExo SExo SExo SExo SExo 
exfoliative toxin A eta eta eta eta eta eta 
leukotoxin LukE/ D lukE, 
LukD 
lukE, LukD lukE, 
LukD 
lukE, LukD lukE, LukD lukE, LukD 
enterotoxin-like 
toxin 
SEnt-like SEnt-like SEnt-like SEnt-like SEnt-like SEnt-like 
glycerol ester 
hydrolase 
geh geh geh geh geh geh 
staphylocoagulase 
precursor 
coa coa coa coa coa coa 
staphylokinase sak sak sak sak sak sak 
complement 
inhibitor SCIN 
scn scn scn scn scn scn 
triacylglycerol 
lipase 
lip lip lip lip lip lip 
IgG-binding protein 
SBI 
isb isb isb isb isb isb 
capsular 
polysaccharide 
synthesis protein  
capC capC capC,G capC,G capC,G capC,G 
  emp emp emp emp emp emp 
Fibronectin binding FnbA and FnbA and FnbA and FnbA and FnbA and FnbA and 
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protein  FnbB FnbB FnbB FnbB FnbB FnbB 
fibrinogen-binding 
protein 
efb efb efb efb efb efb 
Elastin binding 
protein 
ebps ebps ebps ebps ebps ebps 
 
 
 
Table 9 Comparative table showing the plasmid content of each isolate along with its 
position, % identity and accession number.  *High-scoring segment pairs.  
 
  Plas
mid 
%Iden
tity 
Query/
HSP * 
length 
Contig Position in 
contig 
Note Accessio
n 
number 
MB4
6 
rep10 100 477 / 
477 
scaffold
_18 
1008..1484 repL(pE5) M17990 
  rep21 95.27 803 / 
999 
scaffold
_20 
1580..2382 rep(pWBG7
54) 
GQ9003
96.1 
  rep7 99.88 821 / 
821 
scaffold
_0 
347681..34
8501 
rep(MSSA4
76) 
BX5718
57.1 
  rep20 99.89 936 / 
936 
scaffold
_12 
8793..9728 repA(pWBG
753) 
GQ9003
95.1 
MB6 rep7 99.88 821 / 
821 
scaffold
_1 
337273..33
8093 
rep(MSSA4
76) 
BX5718
57.1 
  rep20 99.89 936 / 
936 
scaffold
_16 
5227..6162 repA(pWBG
753) 
GQ9003
95.1 
MB7 rep7 100 496 / 
570 
scaffold
_58 
17..512 ORF(pKH1) SAU386
56 
  rep7 99.88 821 / 
821 
scaffold
_1 
71556..723
76 
rep(MSSA4
76) 
BX5718
57.1 
MB9 rep7 99.88 821 / scaffold 347748..34 rep(MSSA4 BX5718
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821 _0 8568 76) 57.1 
  rep20 99.89 936 / 
936 
scaffold
_16 
5455..6390 repA(pWBG
753) 
GQ9003
95.1 
  rep10 100 477 / 
477 
scaffold
_24 
671..1147 repL(pE5) M17990 
MB1
2 
rep20 99.89 936 / 
936 
scaffold
_20 
5226..6161 repA(pWBG
753) 
GQ9003
95.1 
  rep7 99.88 821 / 
821 
scaffold
_12 
707..1527 rep(MSSA4
76) 
BX5718
57.1 
 
 
Figure 5 Genomic comparison between S. aureus MB6 and ST_11819-97. This 
graphical representation of the genome was generated using CGview server. From 
outside to inside: S. aureus, coding DNA sequence on the forward strand, S. aureus 
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coding DNA sequence on the reverse strand, rRNA and tRNA are colored according to 
the legend inside the first two tracks, third track, which is the blast track (Reference 
strain 11819_97), represents the positions covered by the BLASTN alignment. Inside 
this track, white regions indicate parts of the input sequence that did not yield a blast hit, 
light pink represents parts of the input sequence that yield one blast hit, darker pink 
regions indicate parts of the input sequence that yield several blast hits (ie overlapping 
hits). These often include rRNA or tRNA genes or repetitive sequences for which 
several similar sequences in the CC80 reference strain are found.Then the GC content is 
shown in black and finally the positive and negative GC skew are colored green and 
purple, respectively. 
 
Figure 6 Genomic comparison between S. aureus MB7 and ST_11819-97. This 
graphical representation of the genome was generated using CGview server. From 
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outside to inside: S. aureus, coding DNA sequence on the forward strand, S. aureus 
coding DNA sequence on the reverse strand, rRNA and tRNA are colored according to 
the legend inside the first two tracks, third track, which is the blast track (Reference 
strain 11819_97), represents the positions covered by the BLASTN alignment. Inside 
this track, white regions indicate parts of the input sequence that did not yield a blast hit, 
light pink represents parts of the input sequence that yield one blast hit, darker pink 
regions indicate parts of the input sequence that yield several blast hits (ie overlapping 
hits). These often include rRNA or tRNA genes or repetitive sequences for which 
several similar sequences in the CC80 reference strain are found.Then the GC content is 
shown in black and finally the positive and negative GC skew are colored green and 
purple, respectively. 
 
Figure 7 Genomic comparison between S. aureus MB9 and ST_11819-97. This 
graphical representation of the genome was generated using CGview server. From 
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outside to inside: S. aureus, coding DNA sequence on the forward strand, S. aureus 
coding DNA sequence on the reverse strand, rRNA and tRNA are colored according to 
the legend inside the first two tracks, third track, which is the blast track (Reference 
strain 11819_97), represents the positions covered by the BLASTN alignment. Inside 
this track, white regions indicate parts of the input sequence that did not yield a blast hit, 
light pink represents parts of the input sequence that yield one blast hit, darker pink 
regions indicate parts of the input sequence that yield several blast hits (ie overlapping 
hits). These often include rRNA or tRNA genes or repetitive sequences for which 
several similar sequences in the CC80 reference strain are found.Then the GC content is 
shown in black and finally the positive and negative GC skew are colored green and 
purple, respectively. 
 
Figure 8 Genomic comparison between S. aureus MB12 and ST_11819-97. This 
graphical representation of the genome was generated using CGview server. From 
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outside to inside: S. aureus, coding DNA sequence on the forward strand, S. aureus 
coding DNA sequence on the reverse strand, rRNA and tRNA are colored according to 
the legend inside the first two tracks, third track, which is the blast track (Reference 
strain 11819_97), represents the positions covered by the BLASTN alignment. Inside 
this track, white regions indicate parts of the input sequence that did not yield a blast hit, 
light pink represents parts of the input sequence that yield one blast hit, darker pink 
regions indicate parts of the input sequence that yield several blast hits (ie overlapping 
hits). These often include rRNA or tRNA genes or repetitive sequences for which 
several similar sequences in the CC80 reference strain are found.Then the GC content is 
shown in black and finally the positive and negative GC skew are colored green and 
purple, respectively. 
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Figure 9 Genome atlas of S. aureus MB6. This graphical representation of the genome 
was generated using DNAPLOTTER. From outside to inside: S. aureus, coding DNA 
sequence on the forward strand (blue); S. aureus coding DNA sequence2 on the reverse 
strand (red); ribosomal RNA genes (yellow); tRNA genes (green_ GC% (Black below 
mean and grey above mean); GC skew. The purple arrows represents the phages 
detected in the genome. 
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Figure 10 Genome atlas of S. aureus MB7. This graphical representation of the genome 
was generated using DNAPLOTTER. From outside to inside: S. aureus, coding DNA 
sequence on the forward strand (blue); S. aureus coding DNA sequence on the reverse 
strand (red); ribosomal RNA genes (yellow); tRNA genes (green_ GC% (Black below 
mean and grey above mean); GC skew. The purple arrows represents the phages 
detected in the genome. 
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Figure 11 Genome atlas of S. aureus MB9. This graphical representation of the genome 
was generated using DNAPLOTTER. From outside to inside: S. aureus, coding DNA 
sequence on the forward strand (blue); S. aureus coding DNA sequence on the reverse 
strand (red); ribosomal RNA genes (yellow); tRNA genes (green_ GC% (Black below 
mean and grey above mean); GC skew. The purple arrows represents the phages 
detected in the genome. 
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Figure 12 Genome atlas of S. aureus MB12. This graphical representation of the 
genome was generated using DNAPLOTTER. From outside to inside: S. aureus, coding 
DNA sequence on the forward strand (blue); S. aureus coding DNA sequence on the 
reverse strand (red); ribosomal RNA genes (yellow); tRNA genes (green_ GC% (Black 
below mean and grey above mean); GC skew. The purple arrows represents the phages 
detected in the genome. 
  
